Flex Conference (Physical / Digital)
International Conference on Pharmacy and Molecular Biotechnology - (ICPMB-27)
23rd - 24th March 2027 , La Condamine - Monaco
Access Flexible Participation Categories
This track focuses on the latest advancements in pharmacology, emphasizing innovative approaches in drug discovery and development. Participants will explore novel methodologies and technologies that enhance therapeutic efficacy and safety.
This session will delve into cutting-edge pharmaceutical technologies and their applications in drug delivery systems. Discussions will include formulation strategies, nanotechnology, and targeted delivery mechanisms.
This track highlights the significance of natural products in drug discovery and their role in pharmacognosy. Researchers will present findings on bioactive compounds derived from plants and their therapeutic potentials.
This session addresses the relationship between biopharmaceutics and pharmacokinetics in drug formulation and therapy. Topics will include absorption, distribution, metabolism, and excretion of pharmaceuticals.
This track emphasizes the role of computational chemistry in molecular drug design and development. Participants will discuss the use of in silico methods to predict drug behavior and optimize lead compounds.
This session focuses on the evolving role of clinical pharmacy in enhancing patient-centered care. Discussions will include medication management, therapeutic monitoring, and interdisciplinary collaboration.
This track explores the integration of genomics and proteomics in the development of personalized medicine. Researchers will share insights on how genetic profiling can inform therapeutic strategies.
This session will cover the latest techniques in pharmaceutical analysis and quality control. Emphasis will be placed on ensuring the safety and efficacy of pharmaceutical products through rigorous testing.
This track addresses the economic aspects of pharmacotherapy and its impact on health outcomes. Participants will discuss methodologies for evaluating the cost-effectiveness of pharmaceutical interventions.
This session focuses on the role of biotechnology in the development of novel therapeutics and vaccines. Discussions will include biopharmaceuticals, gene therapy, and the regulatory landscape.
This track highlights the intersection of biotechnology and environmental sustainability. Researchers will present innovative solutions for addressing environmental challenges through biotechnological applications.